Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026652010> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2026652010 endingPage "197" @default.
- W2026652010 startingPage "194" @default.
- W2026652010 abstract "Treatment of patients with metastatic renal cell carcinoma with high-dose interleukin-2 (IL-2) administered as continuous intravenous (CIV) infusion or as bolus injection results in response rates of 15% to 30%; however, toxicities with these regimens have been severe. A trial in which CIV IL-2 was administered at high doses during days 1 to 5 and at reduced doses during days 10 to 20 reported less toxicity without a decrease in response rates. We treated a series of patients with this regimen and our experience is presented.Seventeen patients with metastatic renal cell carcinoma were treated with IL-2 by CIV at a dose of 18 x 10(6) IU/m2/day for 5 days followed by 4 to 6 days of rest followed by 10 days of CIV IL-2 at a dose of 6 x 10(6) IU/m2/day. Five patients also received CT-1501R, a pentoxifylline derivative.There was 1 partial responder (PR) and there were no complete responses. The patient with the PR had a 14 x 9 cm(2) renal tumor with metastases to lung, pancreas, and liver. A surgical resection induced a CR, but he relapsed 9 months later. Severe toxicities included hyponatremia (serum sodium of less than 123 mmol/L) (n=3), biopsy-proven cardiomyopathy (n=1), creatinine more than 4.5 mg/dL (n=7), and sudden death (n=1).We conclude that high-dose CIV IL-2 therapy of renal cell carcinoma results in severe toxicity and cannot be recommended for general use. Alternatives need to be developed." @default.
- W2026652010 created "2016-06-24" @default.
- W2026652010 creator A5004504135 @default.
- W2026652010 creator A5059219836 @default.
- W2026652010 creator A5088131964 @default.
- W2026652010 date "1996-02-01" @default.
- W2026652010 modified "2023-09-27" @default.
- W2026652010 title "High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: The university of Chicago experience" @default.
- W2026652010 cites W1858735933 @default.
- W2026652010 cites W1884121283 @default.
- W2026652010 cites W1904436785 @default.
- W2026652010 cites W1914396593 @default.
- W2026652010 cites W1915622915 @default.
- W2026652010 cites W1939353013 @default.
- W2026652010 cites W2007872459 @default.
- W2026652010 cites W2017543603 @default.
- W2026652010 cites W2036840935 @default.
- W2026652010 cites W2040279923 @default.
- W2026652010 cites W2067133955 @default.
- W2026652010 cites W2101371955 @default.
- W2026652010 cites W2138463196 @default.
- W2026652010 cites W2143381422 @default.
- W2026652010 cites W2149724818 @default.
- W2026652010 cites W2165462116 @default.
- W2026652010 cites W2222964685 @default.
- W2026652010 cites W2270408419 @default.
- W2026652010 cites W2270697554 @default.
- W2026652010 cites W2322553446 @default.
- W2026652010 cites W2326245275 @default.
- W2026652010 doi "https://doi.org/10.1016/s0090-4295(99)80414-2" @default.
- W2026652010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8607232" @default.
- W2026652010 hasPublicationYear "1996" @default.
- W2026652010 type Work @default.
- W2026652010 sameAs 2026652010 @default.
- W2026652010 citedByCount "12" @default.
- W2026652010 countsByYear W20266520102020 @default.
- W2026652010 countsByYear W20266520102022 @default.
- W2026652010 crossrefType "journal-article" @default.
- W2026652010 hasAuthorship W2026652010A5004504135 @default.
- W2026652010 hasAuthorship W2026652010A5059219836 @default.
- W2026652010 hasAuthorship W2026652010A5088131964 @default.
- W2026652010 hasConcept C126322002 @default.
- W2026652010 hasConcept C126894567 @default.
- W2026652010 hasConcept C141071460 @default.
- W2026652010 hasConcept C2777472916 @default.
- W2026652010 hasConcept C2777546739 @default.
- W2026652010 hasConcept C2780306776 @default.
- W2026652010 hasConcept C29730261 @default.
- W2026652010 hasConcept C43376680 @default.
- W2026652010 hasConcept C71924100 @default.
- W2026652010 hasConcept C90924648 @default.
- W2026652010 hasConceptScore W2026652010C126322002 @default.
- W2026652010 hasConceptScore W2026652010C126894567 @default.
- W2026652010 hasConceptScore W2026652010C141071460 @default.
- W2026652010 hasConceptScore W2026652010C2777472916 @default.
- W2026652010 hasConceptScore W2026652010C2777546739 @default.
- W2026652010 hasConceptScore W2026652010C2780306776 @default.
- W2026652010 hasConceptScore W2026652010C29730261 @default.
- W2026652010 hasConceptScore W2026652010C43376680 @default.
- W2026652010 hasConceptScore W2026652010C71924100 @default.
- W2026652010 hasConceptScore W2026652010C90924648 @default.
- W2026652010 hasIssue "2" @default.
- W2026652010 hasLocation W20266520101 @default.
- W2026652010 hasLocation W20266520102 @default.
- W2026652010 hasOpenAccess W2026652010 @default.
- W2026652010 hasPrimaryLocation W20266520101 @default.
- W2026652010 hasRelatedWork W113810927 @default.
- W2026652010 hasRelatedWork W1586374228 @default.
- W2026652010 hasRelatedWork W2003938723 @default.
- W2026652010 hasRelatedWork W2047967234 @default.
- W2026652010 hasRelatedWork W2118496982 @default.
- W2026652010 hasRelatedWork W2364998975 @default.
- W2026652010 hasRelatedWork W2369162477 @default.
- W2026652010 hasRelatedWork W2439875401 @default.
- W2026652010 hasRelatedWork W4238867864 @default.
- W2026652010 hasRelatedWork W2525756941 @default.
- W2026652010 hasVolume "47" @default.
- W2026652010 isParatext "false" @default.
- W2026652010 isRetracted "false" @default.
- W2026652010 magId "2026652010" @default.
- W2026652010 workType "article" @default.